Online CME
    Center for Continuing Education

CME General Information

go to all online cme
General Information Course Presentations CME Posttest

2009/06 (June 2009): The Oncology Pharmacist
CIK 10107
Oral Biologic Therapy versus Chemotherapy for Pretreated Non–small-cell Lung Cancer


Course Objectives Target Audience Method of Participation
Accreditation Term of Approval Disclosure
Disclaimer                                                

Course Objectives
After completing this activity, the reader should be better able to:
• Describe findings of phase 2 and phase 3 trials of gefitinib in non–small-cell lung cancer (NSCLC).
• Discuss the potential clinical implications of the INTEREST trial.
• Explain how patient characteristics such as race, sex, smoking history, and biomarkers such as epidermal growth factor receptor-gene-copy number may affect response to NSCLC therapy.
• Discuss management of skin toxicities associated with epidermal growth factor receptor inhibitor therapy.
top
To Receive A Certificate
Review the material in the Course Presentations section.
Complete the CME Posttest with a score of 7 out of 10 questions correct.
You will then be asked to register and complete a brief course evaluation.
A certificate will be automatically generated for you online.
Target Audience
Registered pharmacists and other interested healthcare professionals, especially those caring for cancer patients.
top
Method of Participation
To receive continuing education credit, learners must:
• Read the article in its entirety
• Take the CE self-assessment test and complete the evaluation

Please note: The learner must answer at least 70% of the questions on the post-test correctly.

The estimated time to complete this activity is 1 hour.

Your continuing education certificate can be printed by following the directions online after successful completion of the post-test and evaluation.
top
Accreditation
acpe logo The University of Nebraska Medical Center, Center for Continuing Education is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The ACPE provider number is 447-000-09-068-H04-P.To receive the 1 contact hour of continuing education credit, pharmacists should complete the activity requirements and evaluation at the conclusion of the activity. Approval is valid from the initial release date of June 15, 2009. The expiration date is June 15, 2010. A statement of credit will be available for printing online upon completion of the post-test with a score of 70% or better and the evaluation instrument.
top
Term of Approval
RELEASE DATE: June 15, 2009
EXPIRATION DATE: June 14, 2010
top
Disclosure
Please refer to printed June 2009 issue of The Oncology Pharmacist.
top
Disclaimer
The opinions or views expressed in this continuing education activity are those of the faculty and do not necessarily reflect the opinions or recommendations of the University of Nebraska Medical Center (UNMC), Center for Continiung Education.

While the University of Nebraska Medical Center, Center for Continuing Education is an ACPE accredited organization, this does not imply endorsement by the UNMC or ACPE of any commercial products affiliated with this activity.
top